Welcome to our dedicated page for IRIDEX SEC filings (Ticker: IRIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IRIDEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IRIDEX's regulatory disclosures and financial reporting.
Iridex Corp (IRIX) Form 4: Romeo R. Dizon, identified as the Chief Financial Officer, reported three transactions on 09/04/2025. The filing shows acquisitions of 404, 96, and 625 common shares at prices of $1.32, $1.345, and $1.39 respectively. After those transactions the filing lists beneficial ownership totals of 54,029, 54,125, and 54,750 shares. The form was signed by an attorney-in-fact on 09/05/2025.
Iridex Corp (IRIX) insider filing shows Chief Financial Officer Romeo R. Dizon, via attorney-in-fact, purchased 625 shares of common stock on 09/03/2025 at $1.36 per share, bringing his beneficial ownership to 53,625 shares.
Romeo R. Dizon, Chief Financial Officer of Iridex Corp (IRIX), reported a purchase of 625 shares of the company's common stock on 09/02/2025 at a price of $1.34 per share, increasing his beneficial ownership to 53,000 shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing documents a routine insider purchase by a named officer and identifies no derivative transactions or additional disclosures.
Iridex Corp (IRIX) Form 4: The reporting person, Romeo R. Dizon (CFO), made a purchase of 625 shares of Iridex common stock on 08/29/2025 at a price of $1.37 per share. Following the transaction, Mr. Dizon beneficially owned 52,375 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Romeo R. Dizon, Chief Financial Officer of Iridex Corp (IRIX), reported multiple open-market purchases totaling 1,005 shares on 08/28/2025. The transactions executed at prices between $1.325 and $1.36 per share increased his direct beneficial ownership from 50,745 shares to 51,750 shares. Individual purchases reported: 50 shares at $1.33, 200 shares at $1.325, 250 shares at $1.35 and 505 shares at $1.36. The Form 4 was signed by an attorney-in-fact on 08/29/2025. No derivative transactions were reported and no additional explanatory text was provided.
Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported purchases of common stock on 08/27/2025. The filing shows three open-market acquisitions totaling 1,000 shares: 500 shares at $1.28, 250 shares at $1.2746, and 250 shares at $1.2964. Each line reports the resulting beneficial ownership rising sequentially to 50,245; 50,495; and 50,745 shares, and ownership is reported as direct. No derivative transactions were reported. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Iridex Corp Chief Financial Officer Romeo R. Dizon reported purchases of common stock on 08/26/2025. The filing shows two open-market buys: 750 shares at $1.26 and 250 shares at $1.25, for a total of 1,000 shares acquired. Following these transactions his beneficial ownership increased to 49,745 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025 and contains no derivative transactions or additional explanatory notes.
Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported four separate purchases of common stock on 08/25/2025. Each transaction (code P) was for 250 shares at prices of $1.25, $1.245, $1.24 and $1.2454, increasing his reported beneficial ownership sequentially to 47,995, 48,245, 48,495 and 48,745 shares. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
Insider purchases increased stake in IRIDEX Corp. Romeo R. Dizon, the company's Chief Financial Officer, acquired a total of 1,000 shares of IRIDEX common stock on 08/22/2025 in three open-market transactions priced at $1.21, $1.22 and $1.23 per share. Following these purchases his reported beneficial ownership rose from 46,995 to 47,745 shares. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
Iridex Corp (IRIX) Form 4: Chief Financial Officer Romeo Dizon reported two purchases on 08/21/2025 totaling 2,000 shares of common stock. The first purchase was 1,000 shares at $1.27 and the second was 1,000 shares at $1.22. Beneficial ownership increased to 46,745 shares following the transactions. The form was signed 08/22/2025 by an attorney-in-fact.